Springer Nature
Browse
12882_2019_1340_MOESM1_ESM.docx (17.57 kB)

Additional file 1: of Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus SandimmunÂŽ Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants

Download (17.57 kB)
journal contribution
posted on 2019-05-14, 05:00 authored by Anja Gäckler, Sebastian Dolff, Hana Rohn, Johannes Korth, Benjamin Wilde, Ute Eisenberger, Anna Mitchell, Andreas Kribben, Oliver Witzke
Figure S1. Inclusion and exclusion criteria. (DOCX 27 kb)

Funding

TEVA Pharmaceuticals BV

History

Usage metrics

    BMC Nephrology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC